血ACE2和死亡或心脏代谢疾病的风险:病例群组分析
Sukrit Narula1, Salim Yusuf2, Michael Chong2
1Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
较高的血血管酶转化酶2 (ACE2) 水平预测死亡和主要心血管事件的风险增加. 这项全球性研究强调ACE2是一个重要的预测因素,甚至超过了某些疾病的传统风险因素.
科学领域:
- 心血管研究
- 内分泌学
- 流行病学
背景情况:
- 氨酸转化酶2 (ACE2) 在氨酸-氨酸系统中起到反调节作用.
- 血ACE2度与不良健康结果之间的关联需要进一步研究.
研究的目的:
- 确定血ACE2度是否与死亡或心血管疾病 (CVD) 事件的风险增加有关.
- 确定血ACE2水平的关键决定因素.
主要方法:
- 使用来自14个国家的10,000多名参与者的前性城市农村流行病学 (PURE) 研究数据进行了病例队列分析.
- 测量了血ACE2度,并评估了与临床终点和风险因素的相关性.
主要成果:
- 血ACE2度升高与全因死亡,心血管死亡,心力衰竭,心肌梗塞,中风和糖尿病的风险显著增加.
- 这些关联仍然强大且独立于传统的心血管风险因素.
- 血ACE2度比BMI,脂质和血压等传统风险因素更强烈地预测死亡.
结论:
- 血ACE2度的增加是主要心血管事件和死亡率的重要预测因素.
- ACE2水平提供了有价值的预后信息,可能超过已确定的临床风险因素.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
相关概念视频
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
